📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Kinase drug discovery 20 years after imatinib: progress and future directions (2021)

First Author: Cohen P

Attributed to: Elucidation of mechanisms that restrict the activation of Toll-Like Receptors and the IL-1 receptor to prevent inflammatory and autoimmune diseases funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41573-021-00195-4

PubMed Identifier: 34002056

Publication URI: http://europepmc.org/abstract/MED/34002056

Type: Journal Article/Review

Parent Publication: Nature Reviews Drug Discovery

Issue: 7

ISSN: 1474-1776